Search

everythinglearnresearchcommunity

for

Search:↓

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Antiandrogen therapy helps treat genetic hair loss.

Higher DHT in male baldness may protect against prostate cancer.

TR3 is mainly found in hair follicle stem cells and may be involved in hair loss.

Plant extracts may help treat hormone-related hair loss.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

Scopolin and scopoletin from Merremia peltata leaves may help treat hair loss and showed promising results in rabbit tests.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Teicoplanin may help treat hair loss by reducing androgen receptors and boosting hair cell growth.

A new method helps detect androgen receptor movement in cells, aiding research on hair loss treatments.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

New acne treatments like clascoterone and minocycline foam are effective, and using antibiotics carefully is important to avoid resistance.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

Treatments for hair loss include hormone modifiers, minoxidil, and hair transplant surgery.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

DHT deficiency in rats reduces sperm content and affects testis structure over time.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Finasteride may help reduce alcohol cravings and related brain activity.

Parthenolide promotes hair growth in mice and may influence pathways related to male pattern baldness.

New treatment improves male hair loss.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.